Search

everythinglearnresearchcommunity

for

Search:↓

A new method using Y-27632 improves the growth and quality of human hair follicle stem cells for tissue engineering and therapy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Puerariae Radix extract may help hair growth by increasing cell activity.

Notch1 helps skin heal by attracting cells that aid repair.

Gefitinib can cause rare scarring hair loss.

DKK proteins could help diagnose and treat various non-cancerous diseases.

Estrogen receptor α controls hair growth cycles and skin thickness in male mice.

Tiny particles from skin cells can help activate hair growth.

Sgk3 is essential for normal hair follicle growth and maintenance.

EGFR inhibitors often cause skin issues like acne and dryness, which can be managed with specific treatments.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

Double stranded RNA helps skin wounds heal by coordinating specific proteins and signaling pathways.

Changes in NRF2 levels may contribute to hair loss in Egyptian men.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

GPCRs are vital for wound healing by affecting cell growth and immune response.

The Fas/FasL pathway may play a role in alopecia areata.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

Fibroblast Growth Factors (FGFs) help maintain and repair skin tissues, which is important for preventing diseases like inflammation, fibrosis, and cancer.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Keratinocyte growth factor significantly alters skin and tissue development.

Reduced AhR signaling in HS tunnels leads to persistent inflammation and microbial imbalance.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Transferrin receptor expression increases iron in mouse skin cells without causing damage.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Topical IKKα inhibitors may help prevent CCS tumours.

Interleukin-1 increases keratin K6 production in skin cells.